Literature DB >> 31142701

Qiliqiangxin Attenuates Oxidative Stress-Induced Mitochondrion-Dependent Apoptosis in Cardiomyocytes via PI3K/AKT/GSK3β Signaling Pathway.

Qifei Zhao1, Hongrong Li1, Liping Chang2,3, Cong Wei3,4, Yujie Yin2, Hongying Bei2, Zhixin Wang3,4, Junqing Liang3,5, Yiling Wu1,2.   

Abstract

Qiliqiangxin capsule (QLQX) is a well-known traditional Chinese medicine that exhibits cardioprotective effects in heart failure patients. However, it remains unclear whether and by which mechanism QLQX attenuates oxidative stress-induced mitochondria-dependent myocardial apoptosis. In vivo, Sprague Dawley (SD) rats received left anterior descending coronary artery ligation for 4 weeks to establish a model of heart failure after acute myocardial infarction, and then were treated with QLQX for another 4 weeks. We evaluated cardiac function, oxidative stress injury, as well as the expressions of mitochondria-dependent apoptosis and its signaling factors. The results indicated that QLQX protected cardiac function and attenuated oxidative stress-induced myocardial apoptosis. Meanwhile, QLQX elevated the Bcl-2 expression, declined the expressions of Bax, cytochrome c, apoptotic protease activating factor-1 (Apaf-1), cleaved-caspase 9 and cleaved-caspase 3, and up-regulated the ratios of phospho-AKT/AKT and phospho-glycogen synthase kinase-3β (GSK3β)/GSK3β. In vitro, H9c2 cardiomyocytes were pretreated with QLQX, then exposed to H2O2 for 24 h. QLQX promoted the proliferation of H9c2 cardiomyocytes induced by H2O2 and reversed oxidative stress damage. Moreover, QLQX inhibited the apoptosis rate and the pro-apoptosis protein expressions, but improved the Bcl-2 expression as well as the ratios of phospho-AKT/AKT and phospho-GSK3β/GSK3β. Meanwhile, it further ameliorated mitochondrion-related apoptosis by inhibiting the mitochondrial fission, mitochondrial permeability transition pore (MPTP) opening, and mitochondrial membrane potential (MMP) decline in H9c2 cardiomyocytes induced by H2O2. In addition, all the effects of QLQX on H2O2-induced mitochondria-dependent apoptosis could be blocked by the phosphoinositide 3-kinase (PI3K) inhibitor, LY294002. We conclude that QLQX may ameliorate oxidative stress-induced mitochondria-dependent apoptosis in cardiomyocytes through PI3K/AKT/GSK3β signaling pathway.

Entities:  

Keywords:  heart failure; myocardial apoptosis; oxidative stress; qiliqiangxin capsule

Year:  2019        PMID: 31142701     DOI: 10.1248/bpb.b19-00050

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  12 in total

1.  Silencing of soluble epoxide hydrolase 2 gene reduces H2O2-induced oxidative damage in rat intestinal epithelial IEC-6 cells via activating PI3K/Akt/GSK3β signaling pathway.

Authors:  Jun Li; Jihui Luo; Yang Zhang; Chunming Tang; Jiang Wang; Chaowu Chen
Journal:  Cytotechnology       Date:  2020-01-06       Impact factor: 2.058

Review 2.  Mitochondrial abnormalities: a hub in metabolic syndrome-related cardiac dysfunction caused by oxidative stress.

Authors:  Aoxue Li; Ningning Zheng; Xudong Ding
Journal:  Heart Fail Rev       Date:  2021-05-05       Impact factor: 4.654

3.  Preclinical study of Shen Qi Li Xin formula in improving the development of chronic heart failure.

Authors:  Yan-Bo Sui; Kui-Kui Zhang; Li-Yun Ling; Rui Fan; Li Liu
Journal:  Histol Histopathol       Date:  2022-03-25       Impact factor: 2.130

Review 4.  Modulatory Effects of Chinese Herbal Medicines on Energy Metabolism in Ischemic Heart Diseases.

Authors:  Fanghe Li; Jinmao Li; Saisai Li; Shuwen Guo; Ping Li
Journal:  Front Pharmacol       Date:  2020-07-03       Impact factor: 5.810

5.  Ubiquitin-specific protease as the underlying gene biomarker for aortic stenosis.

Authors:  Yin Yang; Lian-Qun Wang; Bo-Chen Yao; Zhi-Gang Guo
Journal:  Lipids Health Dis       Date:  2020-05-29       Impact factor: 3.876

6.  Qili Qiangxin Capsule Combined With Sacubitril/Valsartan for HFrEF: A Systematic Review and Meta-Analysis.

Authors:  Qian Xiang; Mengxi Wang; Yuhan Ding; Manlu Fan; Huaqin Tong; Jiandong Chen; Peng Yu; Le Shen; Xiaohu Chen
Journal:  Front Pharmacol       Date:  2022-04-04       Impact factor: 5.988

7.  Mubritinib enhanced the inhibiting function of cisplatin in lung cancer by interfering with mitochondrial function.

Authors:  Jingyao Dong; Dongshan Zhu; Mengmeng Chen; Taiwei Wang; Yan Gao; Wei Liu
Journal:  Thorac Cancer       Date:  2022-04-16       Impact factor: 3.223

8.  Application of network pharmacology and molecular docking approach to explore active compounds and potential pharmacological mechanisms of Aconiti Lateralis Radix Praeparata and Lepidii Semen Descurainiae Semen for treatment of heart failure.

Authors:  Meng-Qi Yang; Cong Chen; Yi-Fei Mao; Yan Li; Xia Zhong; Yi-Ding Yu; Yi-Tao Xue; Yong-Mei Song
Journal:  Medicine (Baltimore)       Date:  2022-08-19       Impact factor: 1.817

9.  Efficacy and safety of Qishen granules for chronic heart failure: A protocol for systematic review and meta-analysis.

Authors:  Junjie Liu; Zixuan Xu; Shuangjie Yang; Kangjia Du; Yili Zhang; Nannan Tan; Xiaoli Sun; Huihui Zhao; Wei Wang
Journal:  Medicine (Baltimore)       Date:  2020-12-24       Impact factor: 1.817

10.  Butein Inhibits Oxidative Stress Injury in Rats with Chronic Heart Failure via ERK/Nrf2 Signaling.

Authors:  Peng Liu; Quanli Pan
Journal:  Cardiovasc Ther       Date:  2022-01-04       Impact factor: 3.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.